EVALUATION OF ADHERENCE TO BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH INFLAMMATORY ARTHRITIS

被引:0
|
作者
Lim, Y. C. [1 ]
Teo, W. G. [2 ]
Eng, M. N. [1 ]
Cheen, H. M. [1 ]
Tay, X. Y. [1 ]
Yeo, S. I. [3 ]
Lim, T. G. [1 ]
机构
[1] Singapore Gen Hosp, Pharm, Singapore, Singapore
[2] Natl Heart Ctr Singapore, Pharm, Singapore, Singapore
[3] Singapore Gen Hosp, Rheumatol & Immunol, Singapore, Singapore
关键词
RHEUMATOID-ARTHRITIS;
D O I
10.1136/annrheumdis-2018-eular.2183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THU0748-HP
引用
收藏
页码:1800 / 1800
页数:1
相关论文
共 50 条
  • [21] Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey
    Bianchi, Gerolamo
    Carletto, Antonio
    Epis, Oscar Massimiliano
    Scioscia, Crescenzio
    Semeraro, Angelo
    Bianchino, Laura
    Bazzichi, Laura
    Lapadula, Giovanni
    Sinigaglia, Luigi
    Lo Monaco, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1045 - S1046
  • [22] ADHERENCE TO DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A QUALITATIVE STUDY IN TWO ETHNIC GROUPS
    Kumar, K.
    Raza, K.
    Gill, P.
    Greenfield, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1061 - 1061
  • [23] Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey
    Bianchi, Gerolamo
    Carletto, Antonio
    Epis, Oscar M.
    Scioscia, Crescenzio
    Semeraro, Angelo
    Donati, Chiara
    Bazzichi, Laura
    Lapadula, Giovanni
    Sinigaglia, Luigi
    Lo Monaco, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [24] DISEASE MODIFYING ANTI-RHEUMATIC DRUG ADHERENCE IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS
    Ayano, Nakayama
    Bruce, Shadbolt
    Allison, Tong
    Kathleen, Tymms
    Chandima, Perera
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 17 - 17
  • [25] USE OF BIOLOGIC OR TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AND THE RISK OF LYMPHOMA IN RHEUMATOID ARTHRITIS
    Singh, N.
    Peterson, A.
    Baraff, A.
    Bhatti, P.
    Gopal, A.
    Smith, N.
    Barton, J.
    Curtis, J.
    Li, C.
    Weiss, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1060 - 1061
  • [26] Use of Biologic or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs and the Risk of Lymphoma in Rheumatoid Arthritis
    Singh, Namrata
    Peterson, Alexander
    Baraff, Aaron
    Gopal, Ajay
    Smith, Nicholas
    Barton, Jennifer
    Curtis, Jeffrey
    Weiss, Noel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2381 - 2382
  • [27] Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers
    Shimada, Hiromi
    Kameda, Tomohiro
    Kanenishi, Kenji
    Miyatake, Nobuyuki
    Nakashima, Shusaku
    Wakiya, Risa
    Kato, Mikiya
    Miyagi, Taichi
    Mansour, Mai Mahmoud Fahmy
    Hata, Toshiyuki
    Kadowaki, Norimitsu
    Dobashi, Hiroaki
    CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1453 - 1458
  • [28] REAL-WORLD USAGE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH PSORIATIC ARTHRITIS IN GERMANY
    Song, J.
    Anjohrin, S.
    Abe, C.
    Banefelt, J.
    Rieem, Dun A.
    Picker, N.
    Kromer, D.
    Fuchs, A.
    Hahn, P.
    Welby, S.
    VALUE IN HEALTH, 2023, 26 (12) : S305 - S305
  • [29] Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs
    Tawaratsumida H.
    Setoguchi T.
    Arishima Y.
    Ohtsubo H.
    Akimoto M.
    Ishidou Y.
    Nagano S.
    Taketomi E.
    Sunahara N.
    Komiya S.
    BMC Research Notes, 10 (1)
  • [30] Comparative Safety of Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for Cancer in Rheumatoid Arthritis
    Sendaydiego, Xavier
    Gold, Laura
    Liew, Jean
    Wysham, K.
    Dubreuil, Maureen
    Andrews, James
    Reid, Pankti
    Liew, David
    Goulabchand, Radjiv
    Singh, Abha
    Hughes, Grant
    Pioro, Mathilde
    Sparks, Jeffrey
    Jarvik, Jeffrey
    Singh, Siddharth
    Singh, Namrata
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3333 - 3336